Santero Therapeutics
Signal active
Organization
Contact Information
Overview
Santero Therapeutics seeks to provide novel medications with fresh modes of action that combat diseases with high resistance. Santero develops antimicrobials with novel modes of action to combat the rise of antibiotic-resistant microorganisms.
About
Industries
Biotechnology, Health Care, Therapeutics
Founded
2021
Employees
1-10
Headquarters locations
Charleroi, Hainaut, Belgium, Europe
Social
Profile Resume
Santero Therapeutics headquartered in Europe, operates in the Biotechnology, Health Care, Therapeutics sector. The company focuses on Biotechnology and has secured $103.5M in funding across 12 round(s). With a team of 1-10 employees, Santero Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Santero Therapeutics, raised $8.6M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
1
Investors
5
Lead Investors
0
Total Funding Amount
$8.6M
Details
1
Santero Therapeutics has raised a total of $8.6M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2023 | Early Stage Venture | 8.6M |
Investors
Santero Therapeutics is funded by 9 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Sambrinvest | - | FUNDING ROUND - Sambrinvest | 8.6M |
| François Fontaine | - | FUNDING ROUND - François Fontaine | 8.6M |
| Santero Therapeutics | - | FUNDING ROUND - Santero Therapeutics | 8.6M |
| SFPIM | - | FUNDING ROUND - SFPIM | 8.6M |